Sign Up to like & get
recommendations!
1
Published in 2022 at "Immunology and Cell Biology"
DOI: 10.1111/imcb.12604
Abstract: Toxicity remains a major limitation of immune checkpoint blockade (ICB) in cancer treatment, and is likely to become increasingly problematic as treatment indications broaden and novel combinations progress. ICB-induced immunerelated adverse events (irAEs) in the…
read more here.
Keywords:
icb;
icb induced;
induced colitis;
colitis ... See more keywords